Key result
IV ribose with 4-hour thallium imaging detects ~7-fold more reversible ischemia defects than late imaging.
Why the study?
Whether early 4-h thallium-201 imaging with ribose infusion would enhance detection of thallium redistribution better than late 24-h imaging without ribose infusion in patients with coronary artery disease was unclear.
Does intravenous ribose infusion with early (4-hour) thallium-201 imaging improve the detection of reversible myocardial perfusion defects compared with late (24-hour) imaging without ribose in patients with coronary artery disease?
RCT (n=15)
Randomized crossover design
Does intravenous ribose infusion with early (4-hour) thallium-201 imaging improve the detection of reversible myocardial perfusion defects compared with late (24-hour) imaging without ribose in patients with coronary artery disease?
Intravenous ribose infusion accelerates thallium-201 redistribution, enabling 4-hour imaging to identify significantly more viable ischemic myocardial territories than standard 24-hour late imaging.
Answers are grounded in this paper and cite their sources.
May enhance early viability detection on thallium imaging in CAD; leaves open whether it should alter practice pending larger trials.
To determine if early (4-h) thallium-201 imaging with ribose infusion would enhance detection of thallium redistribution better than late (24-h) imaging without ribose infusion, 15 patients with coronary artery disease underwent thallium stress tests by both methods within 2 weeks. All 15 patients had quantitative coronary angiography. After immediate postexercise planar imaging during the first of two exercise tests, patients were randomized to receive either intravenous ribose (3.3 mg/kg per min) or a control infusion of saline solution for 30 min. Images performed at 4 h for the ribose study were compared with those at 24 h for the saline control study. During the second test, exercise was carried to the same rate-pressure product and each patient received the opposite infusion. Four-hour postexercise images after ribose infusion identified 21 reversible defects not seen in the 24-h saline study. Three reversible defects were seen only in saline studies, but not with ribose at 4 h (p less than 0.01); 15 reversible defects were seen with both tests. When analyzed with respect to the 31 vascular territories supplied by a coronary artery with a greater than 50% stenosis, 8 territories had reversible defects present in the ribose but not the saline study and the saline study did not demonstrate reversible defects in territories that were seen in the ribose study (p less than 0.01). In 14 of these territories, reversible defects were seen with both tests. In 6 of 15 patients, additional vascular territories with reversible defects were identified after ribose infusion. It is concluded that ribose enhances the detection of thallium redistribution at 4 h compared with 24-h control images in patients with coronary artery disease and, therefore, substantially improves the identification of viable ischemic myocardium.
No takes yet. Share an insight, caveat, or question.
Hegewald et al. (1991) conducted an RCT in Coronary artery disease (n=15). Intravenous ribose infusion with early (4-h) thallium-201 planar imaging vs. Saline solution control infusion for 30 min with late (24-h) thallium-201 planar imaging was evaluated on Detection of reversible thallium-201 perfusion defects (overall defects and within 31 stenosed vascular territories >50%) (p=<0.01). Intravenous ribose with 4-h thallium-201 imaging detected more unique reversible defects than 24-h saline control imaging.
Synapse has enriched 10 related papers. Consider them for comparative context: